Current Multiple Myeloma Treatment Strategies with Novel Agents: A European Perspective

The treatment of multiple myeloma (MM) has undergone significant developments in recent years. The availability of the novel agents thalidomide, bortezomib, and lenalidomide has expanded treatment options and has improved the outcome of patients with MM. Following the introduction of these agents in...

Descripción completa

Detalles Bibliográficos
Autores principales: Ludwig, Heinz, Beksac, Meral, Bladé, Joan, Boccadoro, Mario, Cavenagh, Jamie, Cavo, Michele, Dimopoulos, Meletios, Drach, Johannes, Einsele, Hermann, Facon, Thierry, Goldschmidt, Hartmut, Harousseau, Jean-Luc, Hess, Urs, Ketterer, Nicolas, Kropff, Martin, Mendeleeva, Larisa, Morgan, Gareth, Palumbo, Antonio, Plesner, Torben, San Miguel, Jesús, Shpilberg, Ofer, Sondergeld, Pia, Sonneveld, Pieter, Zweegman, Sonja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AlphaMed Press 2010
Materias:
Academia–Pharma Intersect
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3227886/
https://www.ncbi.nlm.nih.gov/pubmed/20086168
http://dx.doi.org/10.1634/theoncologist.2009-0203

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3227886/
https://www.ncbi.nlm.nih.gov/pubmed/20086168
http://dx.doi.org/10.1634/theoncologist.2009-0203

Ejemplares similares